Diseases, Conditions, Syndromes

Efpeglenatide lowers risk for adverse CV events in T2DM

(HealthDay)—For patients with type 2 diabetes and a history of cardiovascular disease or current kidney disease, the risk for adverse cardiovascular events is lower with efpeglenatide, an exendin-based glucagon-like peptide ...

Obstetrics & gynaecology

Higher-dose DHA in pregnancy tied to fewer early preterm births

(HealthDay)—Supplementation with a higher dose of docosahexaenoic acid (DHA) versus the standard prenatal dose during the second half of pregnancy is associated with a lower rate of early preterm births, according to a ...

Health

USPSTF affirms evidence-based methods for smoking cessation

The U.S. Preventive Services Task Force (USPSTF) concludes that there is substantial net benefit for behavioral and pharmacological therapies for smoking cessation, alone or combined. These findings form the basis of a final ...

Oncology & Cancer

FDA authorizes marketing of EndoRotor system

The U.S. Food and Drug Administration granted marketing authorization to the EndoRotor System, which provides a minimally invasive way to resect and remove necrotic tissue for patients with walled-off pancreatic necrosis ...

Oncology & Cancer

Immune checkpoint inhibitor therapy tied to cardiac event risk

(HealthDay)—Immune checkpoint inhibitor (ICI) treatment is associated with increased cardiac events among patients with lung cancer and malignant melanoma, according to a study published online Dec. 9 in the European Heart ...

Medications

Glecaprevir and pibrentasvir aid HCV-positive kidney transplants

(HealthDay)—By treating or preventing infection, glecaprevir and pibrentasvir (G/P) regimens are promising for increasing access to the transplantation of kidneys from hepatitis C virus (HCV)-positive donors to HCV-negative ...

page 1 from 15